Literature DB >> 26627012

Melphalan, Antimelanoma Immunity, and Inflammation--Letter.

Anna Martner1, Junko Johansson1, Ilan Ben-Shabat2, Roger Olofsson Bagge3.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26627012     DOI： 10.1158/0008-5472.CAN-15-1184

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  2 in total

1.  Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis.

Authors:  Junko Johansson; Roberta Kiffin; Ebru Aydin; Malin S Nilsson; Kristoffer Hellstrand; Per Lindnér; Peter Naredi; Roger Olofsson Bagge; Anna Martner
Journal:  Oncoimmunology       Date:  2019-11-03       Impact factor: 8.110

2.  Presence of tumor-infiltrating CD8+ T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasis.

Authors:  Junko Johansson; Jan Siarov; Roberta Kiffin; Johan Mölne; Jan Mattsson; Peter Naredi; Roger Olofsson Bagge; Anna Martner; Per Lindnér
Journal:  Oncoimmunology       Date:  2020-12-10       Impact factor: 8.110
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.